Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
South Korea flag South Korea · Delayed Price · Currency is KRW
91,600
+100 (0.11%)
At close: Mar 20, 2026

Mezzion Pharma Revenue

Mezzion Pharma had revenue of 2.13B KRW in the quarter ending September 30, 2025, a decrease of -5.89%. This brings the company's revenue in the last twelve months to 7.75B, down -44.95% year-over-year. In the year 2024, Mezzion Pharma had annual revenue of 8.61B, down -72.85%.

Revenue (ttm)
7.75B
Revenue Growth
-44.95%
P/S Ratio
351.84
Revenue / Employee
439.42M
Employees
18
Market Cap
2.78T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20248.61B-23.11B-72.85%
Dec 31, 202331.72B994.76M3.24%
Dec 31, 202230.73B4.07B15.28%
Dec 31, 202126.65B-1.98B-6.92%
Dec 31, 202028.63B10.71B59.79%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics4.56T
Celltrion4.16T
Hanmi Science1.34T
Hugel425.10B
ST Pharm318.32B
Celltrion Pharm274.73B
Sam Chun Dang Pharm.220.74B
ALTEOGEN202.18B
Revenue Rankings